These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26169126)

  • 1. The 2',4'-dihydroxychalcone could be explored to develop new inhibitors against the glycerol-3-phosphate dehydrogenase from Leishmania species.
    Passalacqua TG; Torres FA; Nogueira CT; de Almeida L; Del Cistia ML; dos Santos MB; Dutra LA; Bolzani VS; Regasini LO; Graminha MA; Marchetto R; Zottis A
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3564-8. PubMed ID: 26169126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapeutic potential of chalcones against leishmaniases: a review.
    Tajuddeen N; Isah MB; Suleiman MA; van Heerden FR; Ibrahim MA
    Int J Antimicrob Agents; 2018 Mar; 51(3):311-318. PubMed ID: 28668673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis.
    Ogungbe IV; Ng JD; Setzer WN
    Future Med Chem; 2013 Oct; 5(15):1777-99. PubMed ID: 24144413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones.
    Aponte JC; Castillo D; Estevez Y; Gonzalez G; Arevalo J; Hammond GB; Sauvain M
    Bioorg Med Chem Lett; 2010 Jan; 20(1):100-3. PubMed ID: 19962891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
    Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
    Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Novel Chalcone-Thiosemicarbazones Derivatives as Potential Anti-
    Mendes EP; Goulart CM; Chaves OA; Faiões VDS; Canto-Carvalho MM; Machado GC; Torres-Santos EC; Echevarria A
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31652866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes.
    de Mesquita Barbosa A; Dos Santos Costa S; da Rocha JR; Montanari CA; Giorgio S
    Biomed Pharmacother; 2015 Aug; 74():95-100. PubMed ID: 26349969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual and experimental screening of phenylfuranchalcones as potential anti-Leishmania candidates.
    Ochoa R; García E; Robledo SM; Cardona G W
    J Mol Graph Model; 2019 Sep; 91():164-171. PubMed ID: 31252366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Targets for Chalcones in Antileishmanial Drug Discovery.
    de Santiago-Silva KM; da Silva Gomes GF; Perez CC; da Silva Lima CH; de Lima Ferreira Bispo M
    Mini Rev Med Chem; 2023; 23(14):1414-1434. PubMed ID: 36705240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum.
    Gomes MN; Alcântara LM; Neves BJ; Melo-Filho CC; Freitas-Junior LH; Moraes CB; Ma R; Franzblau SG; Muratov E; Andrade CH
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2459-2464. PubMed ID: 28434763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: In silico ADMET, in vitro activity, docking and molecular dynamic simulations.
    Holanda VN; Silva WVD; Nascimento PHD; Silva SRB; Cabral Filho PE; Assis SPO; Silva CAD; Oliveira RN; Figueiredo RCBQ; Lima VLM
    Bioorg Chem; 2020 Dec; 105():104437. PubMed ID: 33339081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of chalcone derivatives as antileishmanial agents.
    de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
    Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.
    de Oliveira NS; de Souza LG; de Almeida VM; Barreto ARR; Carvalho-Gondim F; Schaeffer E; Santos-Filho OA; Rossi-Bergmann B; da Silva AJM
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300440. PubMed ID: 38048546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brazilian brown propolis elicits antileishmanial effect against promastigote and amastigote forms of Leishmania amazonensis.
    Santana LC; Carneiro SM; Caland-Neto LB; Arcanjo DD; Moita-Neto JM; Citó AM; Carvalho FA
    Nat Prod Res; 2014; 28(5):340-3. PubMed ID: 24261482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chalcones identify cTXNPx as a potential antileishmanial drug target.
    Escrivani DO; Charlton RL; Caruso MB; Burle-Caldas GA; Borsodi MPG; Zingali RB; Arruda-Costa N; Palmeira-Mello MV; de Jesus JB; Souza AMT; Abrahim-Vieira B; Freitag-Pohl S; Pohl E; Denny PW; Rossi-Bergmann B; Steel PG
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009951. PubMed ID: 34780470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase.
    da Silva ER; Brogi S; Grillo A; Campiani G; Gemma S; Vieira PC; Maquiaveli CDC
    Chem Biol Drug Des; 2019 Feb; 93(2):139-146. PubMed ID: 30216691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens.
    Vendrametto MC; Santos AO; Nakamura CV; Dias Filho BP; Cortez DA; Ueda-Nakamura T
    Parasitol Int; 2010 Jun; 59(2):154-8. PubMed ID: 20064628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. trans-Chalcone modulates Leishmania amazonensis infection in vitro by Nrf2 overexpression affecting iron availability.
    Miranda-Sapla MM; Tomiotto-Pellissier F; Assolini JP; Carloto ACM; Bortoleti BTDS; Gonçalves MD; Tavares ER; Rodrigues JHDS; Simão ANC; Yamauchi LM; Nakamura CV; Verri WA; Costa IN; Conchon-Costa I; Pavanelli WR
    Eur J Pharmacol; 2019 Jun; 853():275-288. PubMed ID: 30965057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham.
    de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC
    Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.